CRIS Current Research Information System

MERIGGIOLA, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.057
EU - Europa 5.217
AS - Asia 2.361
AF - Africa 381
SA - Sud America 42
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.069
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.036
GB - Regno Unito 1.278
IT - Italia 1.261
CN - Cina 758
DE - Germania 635
SE - Svezia 621
SG - Singapore 610
VN - Vietnam 548
UA - Ucraina 369
IN - India 268
IE - Irlanda 223
FR - Francia 212
RU - Federazione Russa 203
TG - Togo 151
ZA - Sudafrica 103
BG - Bulgaria 94
EE - Estonia 94
CH - Svizzera 65
CI - Costa d'Avorio 65
JO - Giordania 65
NG - Nigeria 33
BE - Belgio 25
SC - Seychelles 25
FI - Finlandia 24
BR - Brasile 23
JP - Giappone 22
RO - Romania 18
CA - Canada 17
GR - Grecia 15
CZ - Repubblica Ceca 14
NL - Olanda 13
HK - Hong Kong 12
ES - Italia 11
AT - Austria 10
TR - Turchia 10
ID - Indonesia 8
IR - Iran 8
AR - Argentina 7
CL - Cile 7
LB - Libano 7
MY - Malesia 7
UZ - Uzbekistan 7
PT - Portogallo 6
PL - Polonia 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AU - Australia 4
BD - Bangladesh 4
HU - Ungheria 3
IQ - Iraq 3
MA - Marocco 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
UY - Uruguay 3
DK - Danimarca 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
MN - Mongolia 2
MX - Messico 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
SI - Slovenia 2
TW - Taiwan 2
AL - Albania 1
BZ - Belize 1
HN - Honduras 1
IL - Israele 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MU - Mauritius 1
RS - Serbia 1
TJ - Tagikistan 1
Totale 15.069
Salva come PNG Salva come JPEG
Città #
Southend 1.123
Fairfield 750
Chandler 741
Ashburn 676
Singapore 549
Wilmington 407
Woodbridge 378
Santa Clara 373
Seattle 372
Dong Ket 311
Houston 296
Princeton 294
Cambridge 259
Bologna 240
Jacksonville 240
Ann Arbor 231
Dublin 223
Boardman 191
Lomé 151
Nanjing 129
Westminster 124
Turin 114
Padova 107
Sofia 94
Berlin 93
Redmond 75
Abidjan 65
Amman 65
Saint Petersburg 64
Bern 57
Shenyang 54
Milan 53
Jinan 52
Mülheim 51
San Diego 49
Medford 42
Rome 39
Nanchang 38
Beijing 35
Abeokuta 33
Hebei 31
Des Moines 30
Florence 30
Tianjin 30
Changsha 27
Shanghai 27
Zhengzhou 27
Falls Church 26
New York 26
Guangzhou 25
Los Angeles 25
Brussels 24
Mahé 24
Mountain View 23
Paris 23
Naples 21
Olalla 21
Redwood City 21
Helsinki 20
Kuban 20
Dearborn 19
Jiaxing 19
Haikou 17
Hangzhou 17
Verona 17
Norwalk 16
Tokyo 16
Kunming 14
Ningbo 14
Taizhou 14
London 13
Bremen 12
São Paulo 12
Bari 11
Moscow 11
Wuhan 11
Brno 10
Phoenix 10
Washington 10
Modena 9
San Francisco 9
Las Vegas 8
Parma 8
San Jose 8
Bühl 7
Jakarta 7
Lanzhou 7
Stockholm 7
Taiyuan 7
Treviso 7
Amsterdam 6
Andover 6
Buenos Aires 6
Chengdu 6
Hong Kong 6
Mumbai 6
Munich 6
Pune 6
Qingdao 6
Shenzhen 6
Totale 10.146
Salva come PNG Salva come JPEG
Nome #
Fetal cardiac defects and third-trimester maternal serum placental growth factor 195
Prevalence of Sexual Dysfunction among Postmenopausal Women with and without Metabolic Syndrome. 180
Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. 177
Reply to the Letter to the Editor: How Does Sleep Relate to Metabolic Syndrome in Women with Sexual Dysfunction? 174
Accuracy of three-dimensional ultrasound in diagnosis and classification of congenital uterine anomalies. 171
2D and 3D Ultrasound Examination of Labia Minora. 170
A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in Transmen 170
Completeness of exercise reporting among randomized controlled trials on pelvic floor muscle training for women with pelvic organ prolapse: A systematic review 167
A novel circulating hormone of testis origin in humans 161
Body imaging and sexual behavior in lean women with polycystic ovary syndrome. 156
Neonatal hypoxic-ischemic encephalopathy in apparently low risk pregnancies: retrospective analysis of the last five years at the University of Bologna. 155
Androgen receptor expression in the human vagina under different physiological and treatment conditions 153
Effects of Three Different Testosterone Formulations in Female-to-Male Transsexual Persons. 153
Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy 147
Cervical length and risk of antepartum bleeding in women with complete placenta previa 146
L'alterazione della funzione sessuale ha ripercussioni significativamente inferiori sul benessere psicofisico delle donne in menopausa rispetto alle donne in premenopausa. 146
Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. 144
Changes in Vaginal Physiology of Menopausal Women with Type 2 Diabetes 143
Effetti metabolici della somministrazione di testosterone nei soggetti FtM (female to male) affetti da disforia di genere (D.I.G.). 141
10th summit meeting consensus: recommendations for regulatory approval for hormonal male contraception. 140
Le malformazioni vaginali 140
Endocrine care of transpeople part II. A review of cross-sex hormonal treatments, outcomes and adverse effects in transwomen. 140
Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment 138
Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen. 136
Advances in male hormonal contraception. 136
Somministrazione di noretisterone enantato in combinazine con testosterone undecanoato per la contraccezione maschile 135
L'influenza della menopausa sulle caratteristiche della cefalea. 135
Effects of long term high-dose testosterone administration on vaginal epithelium structure and estrogen receptor a and b expression of young women. 135
The impairment of sexual function is less distressing for menopausal than for premenopausal women. 134
Problematiche endocrine della disforia di genere 134
Bone mineral density, body composition and metabolic profiles in adult women with complete androgen insensitivity syndrome and removed gonads using oral or transdermal estrogens 134
A placebo controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effects on anthropometric, metabolic and biochemical parameters 133
Cross-sex hormone administration changes pain in transsexual women and men. 132
Androgens and male contraception 129
Effect of long-term testosterone administration on the endometrium of female to male (FtM) transsexuals. 128
Hysterectomy and Bilateral Salpingoovariectomy in a Transsexual Subject without Visible Scaring. 128
Childhood maltreatment in subjects with male-to-female gender identity disorder. 128
Effects of ospemifene on vaginal epithelium of post-menopausal women. 127
Testosterone decreases adiponectin levels in female to male transsexuals 126
Prevalenza delle disfunzioni sessuali femminili nelle donne in menopausa con sindrome metabolica. 125
Impaired Lipid Profile is a Risk Factor for the Development of Sexual Dysfunction in Women 125
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men. 124
Accettabilita' e assenza di effetti sull'umore, sul comportamento e sulla funzione sessuale di un regime contraccettivo ormonale maschile 124
Menopause affects pain depending on pain type and characteristics. 124
Sexuality and psychopathological aspects in premenopausal women with metabolic syndrome. 124
Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate. 123
Hormonal replacement therapy in menopausal women with history of endometriosis: A review of literature 122
A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery. 121
Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. 121
Prevalence of metabolic syndrome and its components in women with and without pelvic organ prolapse and its association with prolapse severity according to the Pelvic Organ Prolapse Quantification system. 118
Carotid intima-media wall thickness is increased in FtM transsexuals treated with testosterone compared to normal control women. 118
Bone Mineral Density in Women Living with Complete Androgen Insensitivity Syndrome and Intact Testes or Removed Gonads. 117
Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review. 115
Laparoscopic treatment of interstitial twin pregnancy. 114
Safety of hormonal treatment in transgenders. 114
Vaginal Health in Menopausal Women 114
Contraccezione maschile: stato dell'arte. 113
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis 111
The impact of hormonal replacement treatment in postmenopausal women with uterine fibroids: A state-of-the-art review of the literature 110
Dimensional profiles of male to female gender identity disorder: an exploratory research. 109
Update on male hormonal contraception 109
A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen 109
Reproductive and non-reproductive effects of testosterone undecanoate (TU) plus cyproterone acetate (CPA) or norethisterone enanthate (NETE) for male contraception. 108
Chest Wall Masculinization in Female-to-Male Transsexuals: Our Treatment Algorithm and Life Satisfaction Questionnaire 108
Laparoscopic surgery for benign adnexal conditions under spinal anaesthesia: Towards a multidisciplinary minimally invasive approach 108
Transvaginal Ultrasound and Doppler Features of Intraligamental Myomas 107
Male hormonal contraception: a double-blind placebo-controlled study. 106
Endocrine treatment of transsexual persons: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective. 106
Structure of Epithelial and Stromal Compartments of Vulvar and Vaginal Tissue From Women With Vulvo-Vaginal Atrophy Taking Ospemifene. 106
Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. 104
Valutazione dell'influenza dell'accesso chirurgico sulla sessualità nella donna isterectomizzata. 104
Chest-wall contouring in female to male transsexuals 103
Feasibility and safety of two different surgical routes for the eradication of recto-vaginal endometriosis with vaginal mucosa infiltration (Endo-Vag-r study) 103
Knowledge of genito-urinary syndrome of menopause among Italian gynecologists: the DIADEM survey 102
Repeated intramuscular injections of testosterone undecanoate (TU) in FtM transsexuals. 101
Small Variations in Crucial Steps of Tunel Assay Coupled to Flow Cytometry Greatly Affect Measures of Sperm DNA Fragmentation. 101
Prevalence and Psychopathological Determinants of Sexual Dysfunction and Related Distress in Women With and Without Multiple Sclerosis 101
Feminization of the face in male to female transsexuals 99
Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men. 99
Estrogens and testosterone change pain incidence and characteristics in MtF and FtM transsexuals. 98
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men 98
Testosterone Undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals: hormonal and metabolic effects. 97
Ginecologia e Ostetricia. Seconda Edizione. 97
Effects of Testosterone Undecanoate (TU) Administered Alone or in Combination with Letrozole or Dutasteride in Female to Male (FtM) Transsexuals. 97
Testosterone decreases adiponectin levels in female to male transsexuals. 96
Associazione tra anticorpi antitiroide e abortivita' ripetuta (ABRI) 95
Three-dimensional transvaginal sonography in local staging of cervical carcinoma: description of a novel techique and preliminary results. 93
Metabolic effects of 6-month testosterone administration in female to male (FtM) transsexuals 92
Mental Health and Endocrine Telemedicine Consultations in Transgender Subjects During the COVID-19 Outbreak in Italy: A Cross-Sectional Web-Based Survey 92
Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria. 91
Effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male transsexuals (FtM): 90
Urogenital and Reproductive Disorders 89
Current status and future perspectives in male contraception. 88
Contraception across transgender 88
Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis 87
Vaginal metabolites in postmenopausal women with or without vulvo-vaginal atrophy at baseline and after ospemifeme and systemic hormone treatment 87
Hormonal and metabolic effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals. 86
Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG. 85
Sexual counterpart of hormonal male contraception. 85
Gender identity disorder and eating disorders: similarities and differences in terms of body uneasiness. 85
Totale 12.103
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.241
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.382 0 0 0 0 319 312 405 441 390 210 95 210
2020/20212.093 417 148 45 108 96 87 61 104 128 136 129 634
2021/20222.606 242 106 142 219 220 153 75 195 86 125 533 510
2022/20233.168 276 484 158 415 227 258 85 174 568 84 297 142
2023/20241.219 87 151 52 90 116 211 69 135 34 70 119 85
2024/20251.800 124 524 278 253 621 0 0 0 0 0 0 0
Totale 15.464